Current Digital Applications in Psychiatry, Specifically ADHD
Volume 7 Issue 1 August 2021, pages 34-41
Received: 16th March 2021; Accepted: 24th June 2021
Tobias Banaschewski – Medical Director and Deputy Director, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University.
Jan Buitelaar – Department of Cognitive Neuroscience at the Donders Institute, Netherlands.
Manfred Döpfner – University of Cologne, Germany.
Michael Rösler – Saarland University, Forensic Psychology and Psychiatry, 66421 Homburg/Saar, Germany.
Many children and young people with ADHD cannot access treatments due to high clinical demand and lack of alternatives to stimulant and non-stimulant medication. Digital approaches may offer convenient solutions as they are accessible, affordable, scalable, and relatively easy to use. The opportunities with digital technologies span the ADHD disease spectrum, from digital phenotyping providing the potential to measure cognitive function under real-world conditions, to monitoring disease and predicting relapse via the use of passive, wearable technology. Support may be provided in the form of applications (apps) and gamification that may help to motivate children with ADHD and to support parents who are struggling with behaviour management. However, there are significant challenges in developing digital health interventions, and there is an urgent need to find, share, and adopt faster means of establishing a sound evidence-base for these interventions. Results presented here are from the 5th meeting of the International Scientific Board of Experts on ADHD.
Keywords:ADHD; DIGITAL HEALTH INTERVENTIONS (DHIs); DIGITAL PHENOTYPING; METHODOLOGY; REMOTE MONITORING; WEARABLES
Keep up to date with our latest
articles and journals